Host eicosanoids, lipid mediators of inflammation, have been shown to respond to the severity of TB and TB‐diabetes comorbidity,475, 476 and have a significant impact on the outcome of Mtb infection through their correlation with two major counter‐regulatory classes of inflammatory cytokines: IL‐1 and type I IFNs.477. Here, IL1B is linked to tuberculosis.